IBDEI2KO ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41055,1,3,0)
;;=3^Progressive Supranuclear Ophthalmoplegia
;;^UTILITY(U,$J,358.3,41055,1,4,0)
;;=4^G23.1
;;^UTILITY(U,$J,358.3,41055,2)
;;=^5003780
;;^UTILITY(U,$J,358.3,41056,0)
;;=Z79.2^^152^2021^1
;;^UTILITY(U,$J,358.3,41056,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41056,1,3,0)
;;=3^Antibiotics
;;^UTILITY(U,$J,358.3,41056,1,4,0)
;;=4^Z79.2
;;^UTILITY(U,$J,358.3,41056,2)
;;=^321546
;;^UTILITY(U,$J,358.3,41057,0)
;;=Z79.01^^152^2021^2
;;^UTILITY(U,$J,358.3,41057,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41057,1,3,0)
;;=3^Anticoagulants
;;^UTILITY(U,$J,358.3,41057,1,4,0)
;;=4^Z79.01
;;^UTILITY(U,$J,358.3,41057,2)
;;=^5063330
;;^UTILITY(U,$J,358.3,41058,0)
;;=Z79.02^^152^2021^3
;;^UTILITY(U,$J,358.3,41058,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41058,1,3,0)
;;=3^Antiplatelets/Antithrombotics
;;^UTILITY(U,$J,358.3,41058,1,4,0)
;;=4^Z79.02
;;^UTILITY(U,$J,358.3,41058,2)
;;=^5063331
;;^UTILITY(U,$J,358.3,41059,0)
;;=Z79.82^^152^2021^4
;;^UTILITY(U,$J,358.3,41059,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41059,1,3,0)
;;=3^Aspirin
;;^UTILITY(U,$J,358.3,41059,1,4,0)
;;=4^Z79.82
;;^UTILITY(U,$J,358.3,41059,2)
;;=^5063340
;;^UTILITY(U,$J,358.3,41060,0)
;;=Z79.4^^152^2021^6
;;^UTILITY(U,$J,358.3,41060,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41060,1,3,0)
;;=3^Insulin
;;^UTILITY(U,$J,358.3,41060,1,4,0)
;;=4^Z79.4
;;^UTILITY(U,$J,358.3,41060,2)
;;=^5063334
;;^UTILITY(U,$J,358.3,41061,0)
;;=Z79.1^^152^2021^9
;;^UTILITY(U,$J,358.3,41061,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41061,1,3,0)
;;=3^NSAID
;;^UTILITY(U,$J,358.3,41061,1,4,0)
;;=4^Z79.1
;;^UTILITY(U,$J,358.3,41061,2)
;;=^5063332
;;^UTILITY(U,$J,358.3,41062,0)
;;=Z79.891^^152^2021^8
;;^UTILITY(U,$J,358.3,41062,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41062,1,3,0)
;;=3^Long Term Opiate/Opioid Analgesic Use
;;^UTILITY(U,$J,358.3,41062,1,4,0)
;;=4^Z79.891
;;^UTILITY(U,$J,358.3,41062,2)
;;=^5063342
;;^UTILITY(U,$J,358.3,41063,0)
;;=Z79.51^^152^2021^5
;;^UTILITY(U,$J,358.3,41063,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41063,1,3,0)
;;=3^Inhaled Steroids
;;^UTILITY(U,$J,358.3,41063,1,4,0)
;;=4^Z79.51
;;^UTILITY(U,$J,358.3,41063,2)
;;=^5063335
;;^UTILITY(U,$J,358.3,41064,0)
;;=Z79.52^^152^2021^11
;;^UTILITY(U,$J,358.3,41064,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41064,1,3,0)
;;=3^Steroids-Systemic
;;^UTILITY(U,$J,358.3,41064,1,4,0)
;;=4^Z79.52
;;^UTILITY(U,$J,358.3,41064,2)
;;=^5063336
;;^UTILITY(U,$J,358.3,41065,0)
;;=Z79.899^^152^2021^7
;;^UTILITY(U,$J,358.3,41065,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41065,1,3,0)
;;=3^Long Term Current Drug Therapy NEC
;;^UTILITY(U,$J,358.3,41065,1,4,0)
;;=4^Z79.899
;;^UTILITY(U,$J,358.3,41065,2)
;;=^5063343
;;^UTILITY(U,$J,358.3,41066,0)
;;=Z79.84^^152^2021^10
;;^UTILITY(U,$J,358.3,41066,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41066,1,3,0)
;;=3^Oral Hypoglycemic Drugs
;;^UTILITY(U,$J,358.3,41066,1,4,0)
;;=4^Z79.84
;;^UTILITY(U,$J,358.3,41066,2)
;;=^5140432
;;^UTILITY(U,$J,358.3,41067,0)
;;=Z90.13^^152^2022^5
;;^UTILITY(U,$J,358.3,41067,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41067,1,3,0)
;;=3^Acquired Absence of Breasts & Nipples,Bilateral
;;^UTILITY(U,$J,358.3,41067,1,4,0)
;;=4^Z90.13
;;^UTILITY(U,$J,358.3,41067,2)
;;=^5063584
;;^UTILITY(U,$J,358.3,41068,0)
;;=Z90.710^^152^2022^6
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2KO 3790 printed Apr 09, 2024@20:59:22 Page 2
IBDEI2KO ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41055,1,3,0)
+2 ;;=3^Progressive Supranuclear Ophthalmoplegia
+3 ;;^UTILITY(U,$J,358.3,41055,1,4,0)
+4 ;;=4^G23.1
+5 ;;^UTILITY(U,$J,358.3,41055,2)
+6 ;;=^5003780
+7 ;;^UTILITY(U,$J,358.3,41056,0)
+8 ;;=Z79.2^^152^2021^1
+9 ;;^UTILITY(U,$J,358.3,41056,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,41056,1,3,0)
+12 ;;=3^Antibiotics
+13 ;;^UTILITY(U,$J,358.3,41056,1,4,0)
+14 ;;=4^Z79.2
+15 ;;^UTILITY(U,$J,358.3,41056,2)
+16 ;;=^321546
+17 ;;^UTILITY(U,$J,358.3,41057,0)
+18 ;;=Z79.01^^152^2021^2
+19 ;;^UTILITY(U,$J,358.3,41057,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,41057,1,3,0)
+22 ;;=3^Anticoagulants
+23 ;;^UTILITY(U,$J,358.3,41057,1,4,0)
+24 ;;=4^Z79.01
+25 ;;^UTILITY(U,$J,358.3,41057,2)
+26 ;;=^5063330
+27 ;;^UTILITY(U,$J,358.3,41058,0)
+28 ;;=Z79.02^^152^2021^3
+29 ;;^UTILITY(U,$J,358.3,41058,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,41058,1,3,0)
+32 ;;=3^Antiplatelets/Antithrombotics
+33 ;;^UTILITY(U,$J,358.3,41058,1,4,0)
+34 ;;=4^Z79.02
+35 ;;^UTILITY(U,$J,358.3,41058,2)
+36 ;;=^5063331
+37 ;;^UTILITY(U,$J,358.3,41059,0)
+38 ;;=Z79.82^^152^2021^4
+39 ;;^UTILITY(U,$J,358.3,41059,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,41059,1,3,0)
+42 ;;=3^Aspirin
+43 ;;^UTILITY(U,$J,358.3,41059,1,4,0)
+44 ;;=4^Z79.82
+45 ;;^UTILITY(U,$J,358.3,41059,2)
+46 ;;=^5063340
+47 ;;^UTILITY(U,$J,358.3,41060,0)
+48 ;;=Z79.4^^152^2021^6
+49 ;;^UTILITY(U,$J,358.3,41060,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,41060,1,3,0)
+52 ;;=3^Insulin
+53 ;;^UTILITY(U,$J,358.3,41060,1,4,0)
+54 ;;=4^Z79.4
+55 ;;^UTILITY(U,$J,358.3,41060,2)
+56 ;;=^5063334
+57 ;;^UTILITY(U,$J,358.3,41061,0)
+58 ;;=Z79.1^^152^2021^9
+59 ;;^UTILITY(U,$J,358.3,41061,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,41061,1,3,0)
+62 ;;=3^NSAID
+63 ;;^UTILITY(U,$J,358.3,41061,1,4,0)
+64 ;;=4^Z79.1
+65 ;;^UTILITY(U,$J,358.3,41061,2)
+66 ;;=^5063332
+67 ;;^UTILITY(U,$J,358.3,41062,0)
+68 ;;=Z79.891^^152^2021^8
+69 ;;^UTILITY(U,$J,358.3,41062,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,41062,1,3,0)
+72 ;;=3^Long Term Opiate/Opioid Analgesic Use
+73 ;;^UTILITY(U,$J,358.3,41062,1,4,0)
+74 ;;=4^Z79.891
+75 ;;^UTILITY(U,$J,358.3,41062,2)
+76 ;;=^5063342
+77 ;;^UTILITY(U,$J,358.3,41063,0)
+78 ;;=Z79.51^^152^2021^5
+79 ;;^UTILITY(U,$J,358.3,41063,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,41063,1,3,0)
+82 ;;=3^Inhaled Steroids
+83 ;;^UTILITY(U,$J,358.3,41063,1,4,0)
+84 ;;=4^Z79.51
+85 ;;^UTILITY(U,$J,358.3,41063,2)
+86 ;;=^5063335
+87 ;;^UTILITY(U,$J,358.3,41064,0)
+88 ;;=Z79.52^^152^2021^11
+89 ;;^UTILITY(U,$J,358.3,41064,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,41064,1,3,0)
+92 ;;=3^Steroids-Systemic
+93 ;;^UTILITY(U,$J,358.3,41064,1,4,0)
+94 ;;=4^Z79.52
+95 ;;^UTILITY(U,$J,358.3,41064,2)
+96 ;;=^5063336
+97 ;;^UTILITY(U,$J,358.3,41065,0)
+98 ;;=Z79.899^^152^2021^7
+99 ;;^UTILITY(U,$J,358.3,41065,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,41065,1,3,0)
+102 ;;=3^Long Term Current Drug Therapy NEC
+103 ;;^UTILITY(U,$J,358.3,41065,1,4,0)
+104 ;;=4^Z79.899
+105 ;;^UTILITY(U,$J,358.3,41065,2)
+106 ;;=^5063343
+107 ;;^UTILITY(U,$J,358.3,41066,0)
+108 ;;=Z79.84^^152^2021^10
+109 ;;^UTILITY(U,$J,358.3,41066,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,41066,1,3,0)
+112 ;;=3^Oral Hypoglycemic Drugs
+113 ;;^UTILITY(U,$J,358.3,41066,1,4,0)
+114 ;;=4^Z79.84
+115 ;;^UTILITY(U,$J,358.3,41066,2)
+116 ;;=^5140432
+117 ;;^UTILITY(U,$J,358.3,41067,0)
+118 ;;=Z90.13^^152^2022^5
+119 ;;^UTILITY(U,$J,358.3,41067,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,41067,1,3,0)
+122 ;;=3^Acquired Absence of Breasts & Nipples,Bilateral
+123 ;;^UTILITY(U,$J,358.3,41067,1,4,0)
+124 ;;=4^Z90.13
+125 ;;^UTILITY(U,$J,358.3,41067,2)
+126 ;;=^5063584
+127 ;;^UTILITY(U,$J,358.3,41068,0)
+128 ;;=Z90.710^^152^2022^6
